- Home
- PBYI vs CMCM Comparison
PBYI vs CMCM Comparison
Compare PBYI & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CMCM
- Stock Information
- Founded
- PBYI 2010
- CMCM 2009
- Country
- PBYI United States
- CMCM China
- Employees
- PBYI N/A
- CMCM N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CMCM Computer Software: Prepackaged Software
- Sector
- PBYI Health Care
- CMCM Technology
- Exchange
- PBYI Nasdaq
- CMCM Nasdaq
- Market Cap
- PBYI 138.4M
- CMCM 127.6M
- IPO Year
- PBYI N/A
- CMCM 2014
- Fundamental
- Price
- PBYI $2.86
- CMCM $3.61
- Analyst Decision
- PBYI Strong Buy
- CMCM
- Analyst Count
- PBYI 1
- CMCM 0
- Target Price
- PBYI $7.00
- CMCM N/A
- AVG Volume (30 Days)
- PBYI 334.3K
- CMCM 34.9K
- Earning Date
- PBYI 05-01-2025
- CMCM 06-06-2025
- Dividend Yield
- PBYI N/A
- CMCM N/A
- EPS Growth
- PBYI 37.78
- CMCM N/A
- EPS
- PBYI 0.62
- CMCM N/A
- Revenue
- PBYI $230,468,000.00
- CMCM $110,544,725.00
- Revenue This Year
- PBYI N/A
- CMCM $14.27
- Revenue Next Year
- PBYI N/A
- CMCM $39.26
- P/E Ratio
- PBYI $4.61
- CMCM N/A
- Revenue Growth
- PBYI N/A
- CMCM 20.52
- 52 Week Low
- PBYI $2.23
- CMCM $3.02
- 52 Week High
- PBYI $5.34
- CMCM $6.78
- Technical
- Relative Strength Index (RSI)
- PBYI 42.27
- CMCM 34.22
- Support Level
- PBYI $2.83
- CMCM $3.46
- Resistance Level
- PBYI $2.99
- CMCM $3.85
- Average True Range (ATR)
- PBYI 0.17
- CMCM 0.28
- MACD
- PBYI -0.01
- CMCM -0.02
- Stochastic Oscillator
- PBYI 50.00
- CMCM 25.88
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.